Market revenue in 2019 | USD 30.3 million |
Market revenue in 2027 | USD 57.8 million |
Growth rate | 8.4% (CAGR from 2019 to 2027) |
Largest segment | Subcutaneous immunotherapy |
Fastest growing segment | Sublingual immunotherapy |
Historical data | 2016 - 2018 |
Base year | 2019 |
Forecast period | 2020 - 2027 |
Quantitative units | Revenue in USD million |
Market segmentation | Subcutaneous immunotherapy, Sublingual immunotherapy |
Key market players worldwide | Merck KGaA, Allergy Therapeutics PLC, DBV Technologies SA ADR, ASIT biotech, Circassia, Mylan, DMK Pharmaceuticals Corp, Alk-Abello A/S Class B, Desentum, HAL Allergy Group, HollisterStier Allergy, Stallergenes Greer |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to allergy immunotherapy market will help companies and investors design strategic landscapes.
Subcutaneous immunotherapy was the largest segment with a revenue share of 84.16% in 2019. Horizon Databook has segmented the Canada allergy immunotherapy market based on subcutaneous immunotherapy, sublingual immunotherapy covering the revenue growth of each sub-segment from 2016 to 2027.
Allergic rhinitis affects nearly 20% to 25% of the Canadian population. In addition, 50% of the affected population cannot be cured by the use of conventional symptomatic medications. Therefore, key players are focused on the launch of innovative immunotherapy products in Canada.
For instance, ALK submitted application for the Canadian regulatory filing of its investigational tree pollen SLIT tablet in 2019. The review was accepted by the authorities in June 2019. The tablet is indicated for respiratory allergies caused due to allergens from birch, beech, alder, oak, and hazel trees.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada allergy immunotherapy market, including forecasts for subscribers. This country databook contains high-level insights into Canada allergy immunotherapy market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account